Recursion's All-Stock Acquisition of Exscientia plc (EXAI): NVIDIA-Backed Merger to Revolutionize AI-Driven Drug Discovery

Recursion's All-Stock Acquisition of Exscientia plc (EXAI): NVIDIA-Backed Merger to Revolutionize AI-Driven Drug Discovery

The article discusses the evolving landscape of AI investments, focusing on cloud-based AI and the emerging trend of edge AI. It highlights the challenges and opportunities in running AI models on personal devices and the potential growth in the consumer electronics market.

Read More

Did you find this insightful?